These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients. Dhingra VK, Rajpal S, Bhalla P, Yadav A, Jain SK, Hanif M. J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953 [Abstract] [Full Text] [Related]
9. Development of acquired drug resistance in recurrent tuberculosis patients with various previous treatment outcomes. Yoshiyama T, Yanai H, Rhiengtong D, Palittapongarnpim P, Nampaisan O, Supawitkul S, Uthaivorawit W, Mori T. Int J Tuberc Lung Dis; 2004 Jan; 8(1):31-8. PubMed ID: 14974743 [Abstract] [Full Text] [Related]
11. Drug resistance to the first line of antitubercular regimen (a preliminary report). Varaiya A, Gogate A. Indian J Public Health; 1998 Jan; 42(4):126-30. PubMed ID: 10389525 [Abstract] [Full Text] [Related]
13. Results of a national study on anti-mycobacterial drug resistance in El Salvador. Aguilar R, Garay J, Villatoro M, Ramirez M, Villatoro F, Abarca H, Caminero JA. Int J Tuberc Lung Dis; 2005 May; 9(5):514-20. PubMed ID: 15875922 [Abstract] [Full Text] [Related]
14. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda. Umubyeyi AN, Vandebriel G, Gasana M, Basinga P, Zawadi JP, Gatabazi J, Pauwels P, Nzabintwali F, Nyiramasarabwe L, Fissette K, Rigouts L, Struelens MJ, Portaels F. Int J Tuberc Lung Dis; 2007 Feb; 11(2):189-94. PubMed ID: 17263290 [Abstract] [Full Text] [Related]